NEW YORK, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nanorobotics space, today announced the analytical chemistry and positive electrogenic results of wastewater samples treated from a manufacturing plant operated by the world's largest beer manufacturer ("world's largest brewery" or "brewery"). These results reflect Pilus Energy LLC's ("Pilus Energy") wastewater-to-value BactoBot™ treatment results from 6 different samples of wastewater from within the brewery (1 sample per location). The wastewater samples (measured in gallons) treated with Pilus Energy's wastewater-to-value BactoBot were at room temperature and without any additives such as buffers and enzymes. The following results were recorded by the independent Environmental Protection Agency ("EPA") contractor The Shaw Group (Formerly NYSE:SHAW) at the United States EPA Testing and Evaluation facility in Cincinnati, Ohio. Note that on February 13, 2013, The Shaw Group was acquired by the global engineering firm Chicago Bridge and Iron Company NV ("CB & I"). Please view the comprehensive sample test results assembled in the below tables:
| Brewery Wastewater Pollutant Component | Percentage Reduced with RemediBot ™ / GalvaniBot ™ treatment |
| Hydrogen sulfide (H 2 S) | 94.97% |
| Total chemical oxygen demand (COD) | 48.55% |
| Soluble chemical oxygen demand (COD) | 45.25% |
| Total suspended solids (TSS) | 57.89% |
| Total biological oxygen demand (BOD) (5-day residency time) | 81.15% |
| Total organ carbon (TOC) | 53.18% |
The value proposition in both preventing caustic damage from hydrogen sulfide (H2S) and odor masking the environmentally released hydrogen sulfide (H2S) at the brewery equals approximately $225,000.00 USD per year for this plant. These hydrogen sulfide reduction of 94.97% far exceeded the Company's expectations and the Company believes that hydrogen sulfide related damage is not limited to the beer manufacturing industry. The ability to successfully reduce hydrogen sulfide content from wastewater, in and of itself, represents a potential multi-million dollar per year opportunity for the Company.
Additionally Pilus Energy's proprietary GalvaniBot™ generated 5W per m2 of electricity from one of the brewery's wastewater samples, clearly illustrating the wastewater-to-value benefits of the technology platform. The GalvaniBot is named for the 18th century Italian physicist Luigi Galvani who performed one of the first bioelectricity studies of the nervous system; His work ultimately gave rise to the galvanic cell.
Tauriga's CEO Seth M. Shaw commented, "Not including the values extractable from the wastewater, this is the first time that multiple wastewater pollutants were removed by a single solution. It represents a breakthrough in wastewater remediation because it replaces legacy technologies by converging their functions into a single solution. The Company is working diligently to secure the requisite capital to complete the acquisition of Pilus Energy and subsequent to that, commence the commercial pilot tests that are crucial to generating significant future revenues."
The specific results abstracted from the analytical data report provided by The Shaw Group subsidiary Shaw Environmental, Inc. (now a division of CB & I) as the EPA contractor are listed below:
| ACIDITY (pH) | ||||||
| Treatment Unit | pH | |||||
| Raw WASTEWATER | Raw WASTEWATER (Unaltered) + Wastewater-to-value BactoBot | Percentage change | ||||
| Equal Tank | 5.70 | 7.00 | +22.81% | |||
| Travelling Screen | 4.63 | 5.95 | +28.51% | |||
| Superseq | 5.18 | 6.67 | +28.76% | |||
| P.A. Tank | 7.49 | 7.74 | +3.34% | |||
| Scrubber | 8.85 | 8.93 | +0.90% | |||
| Reactor | 6.66 | 7.78 | +16.82% | |||
Comments:
- pH increased due to addition of wastewater-to-value BactoBot in unaltered raw wastewater.
| Hydrogen Sulfide (H2S) | |||
| Treatment Unit | Hydrogen Sulfide (mg/L) | ||
| Raw WASTEWATER | Raw WASTEWATER (Unaltered) + Wastewater-to-value BactoBot | Percentage change | |
| Equal Tank | 0.37 | 0.16 | -56.76% |
| Travelling Screen | 0.00 | 0.00 | 0 |
| Superseq | 0.00 | 0.00 | 0 |
| P.A. Tank | 1.59 | 0.16 | -89.94% |
| Scrubber | 0.11 | 0.21 | +90.91% |
| Reactor | 3.18 | 0.16 | -94.97% |
Comments:
- Hydrogen sulfide concentration decreased due to addition of wastewater-to-value BactoBot in unaltered raw wastewater.
| Total CHEMICAL OXYGEN DEMAND (COD) | |||
| Treatment Unit | Total COD (mg/L) | ||
| Raw WASTEWATER | Raw WASTEWATER + Wastewater-to-value BactoBot | Percentage change | |
| Equal Tank | 6830 | 6760 | -1.02% |
| Travelling Screen | 6680 | 5685 | -14.90% |
| Superseq | 4960 | 3130 | -36.90% |
| P.A. Tank | 1730 | 890 | -48.55% |
| Scrubber | 260 | 325 | +25.00% |
| Reactor | 1040 | 1330 | +27.88% |
Comments:
- Total COD of raw wastewater decreased in all process units except scrubber and reactor due to addition of wastewater-to-value BactoBot .
| Soluble CHEMICAL OXYGEN DEMAND (COD) | |||
| Treatment Unit | Soluble COD (mg/L) | ||
| Raw WASTEWATER | Raw WASTEWATER (unaltered) + Wastewater-to-value BactoBot | Percentage change | |
| Equal Tank | 420.5 | 311 | -26.04% |
| Travelling Screen | 400 | 219 | -45.25% |
| Superseq | 332 | 239 | -28.01% |
| P.A. Tank | 38.5 | 40.5 | +5.19% |
| Scrubber | 68.5 | 237 | +245.99% |
| Reactor | 27 | 66.5 | +146.30% |
Comments:
- Soluble COD of raw wastewater decreased in equal tank, traveling screen and superseq, and increased in P.A. tank, scrubber and reactor due to addition of wastewater-to-value BactoBot .
| TOTAL SOLUBLE SOLIDS (TSS) | |||
| Treatment Unit | TSS (mg/L) | ||
| Raw WASTEWATER | Raw WASTEWATER (Unaltered) + Wastewater-to-value BactoBot | Percentage change | |
| Equal Tank | 1175 | 1270 | +8.09% |
| Travelling Screen | 1150 | 1760 | +53.04% |
| Superseq | 365 | 440 | +20.55% |
| P.A. Tank | 1330 | 560 | -57.89% |
| Scrubber | 10.0 | 150 | +1400.00% |
| Reactor | 1255 | 980 | -21.91% |
Comments:
- TSS of raw wastewater increased in all process units except the reactor due to addition of wastewater-to-value BactoBot .
| Total BIOCHEMICAL OXYGEN DEMAND (BOD) | |||
| Treatment Unit | Total BOD (mg/L) | ||
| Raw WASTEWATER | Raw WASTEWATER (Unaltered) + Wastewater-to-value BactoBot | Percentage change | |
| Equal Tank | 480.9 | 714.7 | +48.62% |
| Travelling Screen | 312.4 | 719.7 | +130.38% |
| Superseq | 266.4 | 739.2 | +177.48% |
| P.A. Tank | 0.00 | 716.5 | +7164900% |
| Scrubber | 237.9 | 37.7 | -81.15% |
| Reactor | 10.4 | 243.2 | +232.80% |
Comments:
- Total BOD of raw wastewater increased in all process units except scrubber due to addition of wastewater-to-value BactoBot .
| TOTAL ORGANIC CARBON (TOC) | |||
| Treatment Unit | TOC (mg/L) | ||
| Raw WASTEWATER | Raw WASTEWATER (Unaltered) + Wastewater-to-value BactoBot | Percentage change | |
| Equal Tank | 1025 | 2045 | +99.51% |
| Travelling Screen | 1399 | 1477 | +5.58% |
| Superseq | 1201 | 1052 | -12.41% |
| P.A. Tank | 98.2 | 69.2 | -29.53% |
| Scrubber | 20.3 | 21.2 | +4.43% |
| Reactor | 282.8 | 132.4 | -53.18% |
Comments:
- TOC of raw wastewater increased in equal tank and travelling screen, and decreased in superseq, P.A. tank and reactor due to addition of wastewater-to-value BactoBot .
On November 25, 2013, the Company signed a definitive agreement to acquire Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga's board of directors, Pilus Energy will become a wholly-owned subsidiary of Tauriga.
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at ( www.tauriga.com ).
About Pilus Energy LLC
A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). For more information, please visit Pilus Energy's web site, ( www.pilusenergy.com ).
DISCLAIMER:
Forward-Looking Statements:
Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
For further information regarding Tauriga Sciences, Inc.: Mr. Seth M. Shaw Chairman & Chief Executive Officer Tauriga Sciences, Inc. www.tauriga.com New York: +1-917-796-9926 Montreal: +1-514-840-3697 Email:
